Excess incidence of ALS in young Gulf War veterans

Neurology

Volumn 61, Issue 6, 2003, Pages 750-756

  Haley, Robert W ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONFIDENCE INTERVAL; CONTROLLED STUDY; ELECTROMYOGRAPHY; EPIDEMIOLOGICAL DATA; HUMAN; INCIDENCE; MEDICAL RECORD; MORTALITY; POISSON DISTRIBUTION; PRIORITY JOURNAL; STATISTICS; WAR;

EID: 0141860155     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.61.6.750     Document Type: Article

References (45)

1. Haley RW, Fleckenstein JL, Marshall WW, McDonald GG, Kramer GL, Petty F. Effect of basal ganglia injury on central dopamine activity in Gulf War syndrome: correlation of proton magnetic resonance spectroscopy and plasma homovanillic acid. Arch Neurol 2000;57:1280-1285.
2. Thompson J. Statement of Joseph Thompson Under Secretary for Benefits, Department of Veterans Affairs, before the House Committee on Veterans' Affairs, Subcommittee on Benefits, October 26, 1999. Available at: http://veterans.house.gov/hearings/schedule106/oct99/10-2699/dva.htm. Accessed June 5, 2003.
3. Presumptions of service connection for illnesses associated with service in the Persian Gulf during the Persian Gulf War 1998; 38 U.S.C.: 1118. Available at: http://www4.law.cornell.edu/uscode/unframed/38/1118.html. Accessed June 5, 2003.
4. Brooks BR. Clinical epidemiology of amyotrophic lateral sclerosis. Neurol Clin 1996;14:399-420.
5. Kang HK, Bullman TA. Mortality among U.S. veterans of the Persian Gulf War. N Engl J Med 1996;335:1498-1504.
6. Donnelly M, Donnelly D. Falcon's Cry: A Desert Storm Memoir. Westport, CT: Praeger Publishers, 1998.
7. Gulf War veterans' illnesses: the epidemiology of ALS. US Medicine, January 6, 2000.
8. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial "Clinical limits of amyotrophic lateral sclerosis" workshop contributors. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. J Neurol Sci 1994;124(suppl):96-107.
9. The Amyotrophic Lateral Sclerosis Functional Rating Scale. Assessment of activities of daily living in patients with amyotrophic lateral sclerosis. The ALS CNTF treatment study (ACTS) phase I-II Study Group. Arch Neurol 1996;53:141-147.
10. Armon C. Motor neuron disease. In: Gorelick PB, Alter M, l, eds. Handbook of Neuroepidemiology. New York: Marcel Dekker, 1994:407-454.
11. Breslow NE, Day NE. Statistical methods in cancer research. Vol 2. The design and analysis of cohort studies. Lyon, France: International Agency for Research on Cancer, 1987:65-72;91-103.
12. Riggs JE. Longitudinal Gompertzian analysis of amyotrophic lateral sclerosis mortality in the U.S., 1977-1986: evidence for an inherently susceptible population subset. Mech Ageing Dev 1990;55:207-220.
13. Mitsumoto H, Chad DA, Pioro EP. Amyotrophic Lateral Sclerosis. Philadelphia; FA Davis Company, 1998:23, 155.
14. Sorenson EJ, Stalker AP, Kurland LT, Windebank AJ. Amyotrophic lateral sclerosis in Olmsted County, Minnesota, 1925 to 1998. Neurology 2002;59:280-282.
15. Magnus T, Beck M, Giess R, Puls I, Naumann M, Toyka KV. Disease progression in amyotrophic lateral sclerosis: predictors of survival. Muscle Nerve 2002;25:709-714.
16. Chio A, Mora G, Leone M, et al. Early symptom progression rate is related to ALS outcome: a prospective population-based study. Neurology 2002;59:99-103.
17. Bharucha NE, Schoenberg BS, Raven RH, Pickle LW, Byar DP, Mason TJ. Geographic distribution of motor neuron disease and correlation with possible etiologic factors. Neurology 1983;33:911-915.
18. National Center for Health Statistics, Centers for Disease Control and Prevention. Vital Statistics of the United States, 1979-1998. Washington, DC: US Government Printing Office, 2001.
19. Haenszel W, Loveland DB, Sirken MG. Lung cancer mortality as related to residence and smoking histories, I. white males. J Nat Cancer Inst 1962;28:947-1001.
20. Armon C, Daube JR, O'Brien PC, Kurland LT, Mulder DW. When is an apparent excess of neurologic cases epidemiologically significant? Neurology 1991;41:1713-1718.
21. Belsh JM. Diagnostic challenges in ALS. Neurology 1999;53:S26-S30.
22. Smith TC, Gray GC, Knoke JD. Is systemic lupus erythematosus, amyotrophic lateral sclerosis, or fibromyalgia associated with Persian Gulf War service? An examination of Department of Defense hospitalization data. Am J Epidemiol 2000;151:1053-1059.
23. Yoshida S, Mulder DW, Kurland LT, Chu CP, Okazaki H. Follow-up study on amyotrophic lateral sclerosis in Rochester, Minn., 1925 through 1984. Neuroepidemiology 1986;5:61-70.
24. Annegers JF, Appel SH, Perkins P, Lee J. Amyotrophic lateral sclerosis mortality rates in Harris County, Texas. Adv Neurol 1991;56:239-243.
25. McGuire V, Longstreth WTJ, Koepsell TD, van Belle G. Incidence of amyotrophic lateral sclerosis in three counties in western Washington state. Neurology 1996;47:571-573.
26. Traynor BJ, Codd MB, Corr B, Forde C, Frost E, Hardiman O. Incidence and prevalence of ALS in Ireland, 1995-1997: a population-based study. Neurology 1999;52:504-509.
27. Kondo K, Tsubaki T. Changing mortality patterns of motor neuron disease in Japan. J Neurol Sci 1977;32:411-424.
28. Davenport RJ, Swingler RJ, Chancellor AM, Warlow CP. Avoiding false positive diagnoses of motor neuron disease: lessons from the Scottish Motor Neuron Disease Register. J Neurol Neurosurg Psychiatry 1996;60:147-151.
29. Chio A, Magnani C, Oddenino E, Tolardo G, Schiffer D. Accuracy of death certificate diagnosis of amyotrophic lateral sclerosis. J Epidemiol Community Health 1992;46:517-518.
30. Jokelainen M. Amyotrophic lateral sclerosis in Finland. I: an epidemiologic study. Acta Neurol Scand 1977;56:185-193.
31. Juergens SM, Kurland LT, Okazaki H, Mulder DW. ALS in Rochester, Minnesota, 1925-1977. Neurology 1980;30:463-470.
32. Buckley J, Warlow C, Smith P, Hilton-Jones D, Irvine S, Tew JR. Motor neuron disease in England and Wales, 1959-1979. J Neurol Neurosurg Psychiatry 1983;46:197-205.
33. O'Malley F, Dean G, Elian M. Multiple sclerosis and motor neurone disease: survival and how certified after death. J Epidemiol Community Health 1987;41:14-17.
34. Hoffman PM, Brody JA. The reliability of death certificate reporting for amyotrophic lateral sclerosis. J Chronic Dis 1971;24:5-8.
35. Kahana E, Zilber N. Changes in the incidence of amyotrophic lateral sclerosis in Israel. Arch Neurol 1984;41:157-160.
36. Belsh JM, Schiffman PL. Misdiagnosis in patients with amyotrophic lateral sclerosis. Arch Intern Med 1990;150:2301-2305.
37. Belsh JM, Schiffman PL. The amyotrophic lateral sclerosis (ALS) patient perspective on misdiagnosis and its repercussions. J Neurol Sci 1996;139(suppl):110-116.
38. Ludolph AC, Knirsch U. Problems and pitfalls in the diagnosis of ALS. J Neurol Sci 1999;165(suppl):S14-S20.
39. Committee on Health Effects Associated with Exposures During the Gulf War, Division of Health Promotion and Disease Prevention, Institute of Medicine. Gulf War and Health: Volume 1. Depleted Uranium, Sarin, Pyridostigmine Bromide Vaccines. Washington, DC: National Academy Press, 2000. Available at: www.nap.edu. Accessed June 5, 2003.
40. McGuire V, Longstreth WTJ, Nelson LM, et al. Occupational exposures and amyotrophic lateral sclerosis: a population-based case-control study. Am J Epidemiol 1997;145:1076-1088.
41. Kurtzke JF. Risk factors in amyotrophic lateral sclerosis. Adv Neurol 1991;56:245-270.
42. Neilson S, Robinson I, Nymoen EH. Longitudinal analysis of amyotrophic lateral sclerosis mortality in Norway, 1966-1989: evidence for a susceptible subpopulation. J Neurol Sci 1994;122:148-154.
43. Riggs JE. Trauma, axonal injury, and amyotrophic lateral sclerosis: a clinical correlate of a neuropharmacologic model. Clin Neuropharmacol 1995;18:273-276.
44. Brown RHJ. Amyotrophic lateral sclerosis: insights from genetics. Arch Neurol 1997;54:1246-1250.
45. Riggs JE. Amyotrophic lateral sclerosis, heterogeneous susceptibility, trauma, and epidemiology. Arch Neurol 1996;53:225-227.